Press Releases

Date	Title	Company
10-Jan-2023	Santhera enters into CHF 5 million share exchange agreement	Santhera Pharmaceuticals
10-Jan-2023	BioMed Realty Becomes New Strategic Partner to Babraham Research Campus Accelerate@Babraham Bio-incubator Programme	The Babraham Research Campus
10-Jan-2023	Spago Nanomedical publishes scientific paper on positive preclinical data with Tumorad® as treatment of solid tumors	Spago Nanomedical
10-Jan-2023	Santhera and ReveraGen Announce FDA Acceptance of New Drug Application for Vamorolone in Duchenne Muscular Dystrophy	Santhera Pharmaceuticals
10-Jan-2023	Appointment of Interim Chief Commercial Officer	Aptamer Group plc
10-Jan-2023	New process created by team from Aston University to solubilise fats in water heralds a revolution in both CBD and drug delivery.	Max Bio+
10-Jan-2023	STORM Therapeutics Expands R&D Leadership Team	STORM Therapeutics
10-Jan-2023	ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technology	B3C newswire
10-Jan-2023	Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes	Sernova Corp.
10-Jan-2023	BRAIN Biotech AG: BRAIN Group's Akribion Genomics business will prioritize the development of therapeutic applications within its CRISPR technology platform	BRAIN Biotech AG
10-Jan-2023	BRAIN Biotech AG: prioritizing development of therapeutic applications of the Akribion Genomics technology platform (genome-editing)	BRAIN Biotech AG
10-Jan-2023	Shift to consumer-first mindset is highest priority for digital pharma products going into 2023	Graphite Digital
10-Jan-2023	Phastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in Denmark	Phastar
10-Jan-2023	Medios AG: Successful completion of the acquisition of bbw – Significant expansion of compounding volume	Medios AG
10-Jan-2023	No More Needles: TRUMPF and RSP Systems Want to Make Blood Glucose Monitoring Easier for People with Diabetes	TRUMPF Photonic Components
10-Jan-2023	iTeos Provides Business Updates and Clinical Development Plans for 2023	iTeos Therapeutics
10-Jan-2023	atai Life Sciences Company GABA Therapeutics Announces Positive Final Results from Phase 1 Single and Multiple Ascending Dose Trial of GRX-917	atai Life Sciences
10-Jan-2023	SK PHARMTECO APPOINTS DAVID LOWNDES AS CHIEF OPERATING OFFICER	SK PHARMTECO
10-Jan-2023	Sirio Pharma Successfully Completes the Acquisition of Best Formulations	Sirio Pharma
10-Jan-2023	Lynred launches HEROIC, €18M European Defence Fund project to produce strategic electronics for next-generation infrared sensors	Andrew Lloyd Associates